SCHEMBL6848810

SCHEMBL6848810

[CH2]C(C)C(=O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10815842 0.74
SCHEMBL127653 0.74
SCHEMBL11426097 0.72
SCHEMBL9243318 0.72 TP53 (0.41)
2-Oxoisovalerate SCHEMBL1462512 0.72 TP53 (0.41)
SCHEMBL752677 0.72
2-Oxoisovalerate SCHEMBL42329 0.72
2-Oxoisovalerate SCHEMBL30552298 0.72
SCHEMBL3679158 0.71
2-Oxoisovalerate SCHEMBL468254 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1487789-A2 IMPROVEMENTS IN PHARMACEUTICAL COMPOSITIONS Charterhouse Therapeutics Ltd. (GB) 2004-12-22 EP disclosed
WO-2003082813-A2 IMPROVEMENTS IN PHARMACEUTICAL COMPOSITIONS CHARTERHOUSE THERAPEUTICS LIMITED (GB) 2003-10-09 WO disclosed
EP-1240171-A1 CYCLOPENTENEONE DERIVATIVES Charterhouse Therapeutics Ltd. (GB) 2002-09-18 EP disclosed
WO-2001044254-A1 CYCLOPENTENEONE DERIVATIVES CHARTERHOUSE THERAPEUTICS LTD. (GB) 2001-06-21 WO disclosed
CN-1023801-C 2-Oxa-isocephem compounds, compositions containing same and processes for preparing same OTSUKA PHARMA CO LTD (JP) 1994-02-16 CN disclosed
CN-88102161-A 2-oxa-isocephem compounds, compositions containing them and processes for their preparation 1988-10-05 CN disclosed